This activity serves as an educational tool for pharmacists seeking Board Certified Psychiatric Pharmacist (BCPP) Recertification credit and other pharmacists and health care providers seeking advanced education in patient management, disease state management, information management, and health policy and practice management in the field of psychiatric pharmacy.
Content
The Clinical Application Series is an application-based continuing pharmacy education (CPE) activity designed to improve competency of partcipants. An application-based CPE activity requires that participants apply the information learned. In an application-based CPE activity, the learning objectives are written at a higher level in order to assess the learners’ ability to use the information that is learned at the current level of practice by Board Certified Psychiatric Pharmacists. The examination for this product often features case studies requiring that the participant apply the principles learned through the readings.
The Clinical Application Series includes:
Online access to the recorded speakers' audio presentations synchronized with their slide presentations.
For pharmacists, 5 hours of ACPE credit and 5 hours of BCPP Recertification credit achieved by successfully completing the online CPNP recertification examination.
Access to the CPNP testing center with exam submission due on or before October 19, 2021.
Course Requirements
To satisfactorily complete the Clinical Application Series and receive 5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:
Abide by a confidentiality and honesty statement requiring individual completion of the Recertification education.
Complete an online assessment on or before the deadline of October 19, 2021.
Meet the minimum passing score to be determined by a panel of experts within four (4) weeks following the exam deadline.
Completion of an activity evaluation form.
Partial credit is not available for individual topics within the programming; it is either all 5 hours of Clinical Application Series credit or none.
You will proceed through the following steps to satisfactorily complete this course:
Sign in (or create a FREE account).
Register for this course.
Complete the pre-test before starting the activity.
Review the full content of the activity and reflect upon its teachings.
Complete the post-test at the end of the activity no later than the closing activity date.
Complete the evaluation at the end of the activity.
Wait for the official review of exam questions within 4 weeks following the closing date.
Receive a passing grade (76%).
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Participants successfully passing the required assessment/examination will obtain both ACPE and BCPP recertification credit. Credit is awarded in the calendar year the assessment is completed. ACPE credit is reported through CPE Monitor within days of examination submission, while BCPP recertification credit is reported to BPS within 6 weeks after the examination deadline.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended,
or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat
or FoxIt
An adequate device and Internet connection:
Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent);
Memory: 4 GB;
Storage: 5 GB available;
Internet speed: 4.0 Mbps (up/down)
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Faculty Information
Elayne D. Ansara, PharmD, BCPS, BCPP Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS Michelle Geier, PharmD, BCPP Sarah T. Melton, PharmD, BCPP, BCACP, FASCP Stephen R. Saklad, PharmD, BCPP
Elayne D. Ansara, PharmD, BCPS, BCPP
Clinical Pharmacy Specialist – Mental Health
Veteran Health Indiana
Indianapolis, IN
Dr. Ansara graduated with her Doctor of Pharmacy from Purdue University in 2006. She began her post-graduate training at Indiana University Health in Indianapolis, Indiana, where she completed her PGY1 Pharmacy Residency. She pursued specialty training in psychiatric pharmacy, completing her PGY2 residency with Eskenazi Health & Purdue University. Upon completion of residency she began her career as an inpatient psychiatric pharmacist at Eskenazi Health. She is board certified in Pharmacotherapy and Psychiatric Pharmacy.
In her current role she is a Clinical Pharmacy Specialist in Mental Health at Veteran Health Indiana in Indianapolis. Her practice is in the Older Adult Clinic, a geropsychiatry clinic, within the larger general outpatient Mental Health Clinic. Within this clinic she provides comprehensive medication management services to Veterans under an approved scope of practice. She also serves as the Residency Program Director for the PGY2 Psychiatric Pharmacy residency. She also serves as the co-chair for the Clinical Pharmacy Practice Office Mental Health Subject Matter Expert Workgroup.
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS
Professor of Pharmacotherapy & Outcomes Science and Neurosurgery
Virginia Commonwealth University School of Pharmacy
Richmond, VA
Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS is Professor of Pharmacotherapy & Outcomes Sciences and Neurosurgery at Virginia Commonwealth University (VCU) School of Pharmacy, Medical College of Virginia Campus, in Richmond. She is also a Neurocritical Care Clinical Pharmacist at VCU Health and a Past President of the Neurocritical Care Society. Dr. Brophy received her PharmD from the University of Arizona, College of Pharmacy in Tucson and her postgraduate training includes residencies in Critical Care and Pharmacy Practice at the University of Kentucky Medical Center in Lexington. Dr. Brophy’s research interests include effective treatments strategies for traumatic brain injury, brain injury biomarkers, neurocritical care, hemostasis, stroke, sedation and status epilepticus. She is an investigator for the National Institutes of Health, U.S. Department of Defense and industry-funded studies. Dr. Brophy is an invited speaker at national and international conferences and has multiple peer-reviewed publications and book chapters in the area of neurocritical care.
Michelle Geier, PharmD, BCPP
Psychiatric Clinical Pharmacist Supervisor
San Francisco Department of Public Health
San Francisco, CA
Sarah T. Melton, PharmD, BCPP, BCACP, FASCP
Professor of Pharmacy Practice
Gatton College of Pharmacy at East Tennessee State University
Johnson City, TN
Sarah T. Melton is Professor of Pharmacy Practice at the Gatton College of Pharmacy at East Tennessee State University (ETSU). She is the Clinical Pharmacist at the Johnson City Community Health Center and the ETSU Center of Excellence for HIV/AIDS Care. Dr. Melton received her Bachelor of Science in Pharmacy (1991) and Doctor of Pharmacy (1994) degrees from Virginia Commonwealth University/Medical College of Virginia School of Pharmacy (VCU). She completed a Fellowship in Psychiatric Pharmacy at VCU in 1996. She has been a board-certified psychiatric pharmacist (Board of Pharmaceutical Specialties) since 1997 and a board-certified ambulatory care pharmacist since 2011. She is a Fellow of the American Society of Consultant Pharmacists. She performs comprehensive medication management in the areas of psychiatric and neurologic pharmacy, substance use disorders, and other primary care disorders.
Stephen R. Saklad, PharmD, BCPP
Clinical Professor and Director of Psychiatric Pharmacy, The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division and Adjoint Professor of Medicine, University of Texas Health San Antonio
San Antonio, TX
Dr. Saklad is Clinical Professor and Director of Psychiatric Pharmacy at The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division, and consultant to San Antonio State Hospital (SASH).
Dr. Saklad received his baccalaureate degree in Bacteriology from the University of California, Los Angeles, and his Pharm.D. at the University of Southern California. He completed a NIMH training fellowship at the Nebraska Psychiatric Institute. After completing his training, he joined the faculty of The University of Texas at Austin, College of Pharmacy and the clinical staff at SASH as the first clinical pharmacist employed by the Texas state hospital system.
During his over 40-year career, Dr. Saklad has provided clinical care, education, and research in a variety of settings and treatment roles at SASH. He teaches P2 & P3 students at The University of Texas about psychiatric and neurologic pharmacotherapy and is the course director for the clinical presentation skills laboratory. He precepts and mentors P3 & P4 students on experiential rotations and in several courses.
In 1988, Dr. Saklad helped to create The University of Texas at Austin College of Pharmacy’s Psychiatric Pharmacotherapy Update and has chaired the meeting since 2007. He has been an investigator on research studies. He is a consultant for several companies on research studies, psychiatric pharmacy, improving clinical care, educational activities, and treatment issues. He is an expert witness on behalf of both defendants and plaintiffs. He has authored peer-reviewed poster presentations and journal articles as well as written book chapters and edited books. He has received several awards. He is a frequently requested speaker.
Dr. Saklad helped to organize and became a founding member of College of Psychiatric and Neurologic Pharmacists (CPNP) in 1998 and the CPNP Foundation in 2012. He initiated and developed the first websites for the UT Austin College of Pharmacy in 1994, CPNP in 1997, and helped with the CPNP Foundation’s in 2015. He has served the CPNP in a number of roles including Board Member, committees, and was the Founding Senior Editor of the Mental Health Clinician. Dr. Saklad is was the Treasurer of the CPNP Foundation 2014-2019 and a current member of the CPNP Business Development Committee.
Learning Objectives
Topic
Antipsychotic Adverse Effects Comparison
ACPE #:0284-0000-21-003-L01-P (Application)
Speaker: Stephen Saklad, PharmD, BCP
Learning Objectives:
Analyze the relationship between receptor binding affinities and the adverse effect profiles of antipsychotics.
Compare the advantages and disadvantages of antipsychotics based on their adverse effect profiles.
Select the most appropriate antipsychotic for a patient based on adverse effect potential and past medical history.
Harm Reduction Strategies in Opioid Use Disorder
ACPE #: 0284-0000-21-004-L08-P (Application)
Speakers: Michelle Geier, PharmD, BCPP
Learning Objectives:
Assess the utility of harm reduction strategies for patients with opioid use disorder (OUD).
Advocate for harm reduction strategies for patients with OUD based on ethical and legal considerations.
Propose strategies to implement evidence-based harm reduction programs for patients with OUD.
Role of Newer Antidepressants in Social Anxiety Disorder (SAD)
ACPE #: 0284-0000-21-005-L01-P (Application)
Speaker: Sarah Melton, PharmD, BCPP, BCACP, FASCP
Learning Objectives:
Evaluate a patient for social anxiety disorder using validated screening tools.
Compare the efficacy and/or adverse effects of current treatment options for social anxiety disorder.
Assess the role of newer antidepressants in the treatment of social anxiety disorder.
Develop a pharmacologic treatment plan for the management of social anxiety disorder.
Pharmacologic Management of Insomnia with Sleep Apnea
ACPE #: 0284-0000-21-006-L01-P (Application)
Speaker: Elayne Ansara, PharmD, BCPS, BCPP
Learning Objectives:
Recommend strategies to improve adherence to continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea and co-morbid insomnia.
Evaluate the risks and/or benefits of sedative-hypnotics for treatment of insomnia in patients with co-morbid obstructive sleep apnea.
Create a pharmacologic treatment plan for management of insomnia in a patient with co-morbid obstructive sleep apnea who has tried and failed non-pharmacologic interventions.
Assess a patient with epilepsy for risk factors and symptoms that meet clinical presentation for acute repetitive seizures (ARS) and status epilepticus (SE).
Recommend an appropriate rescue treatment for a patient at risk for ARS and SE based on the clinical literature and specific patient factors.
Educate patients with epilepsy and their caregivers on the administration and monitoring of treatments for ARS.
Continuing Education Credit and Disclosures
Activity Dates:04/20/2021 - 10/24/2021 ACPE Contact Hours: 5 ACPE Numbers: 0284-0000-21-005-H01-P (Application), 0284-0000-21-006-H01-P (Application), 0284-0000-21-007-H01-P (Application), 0284-0000-21-004-H08-P (Application), 0284-0000-21-003-H01-P (Application) Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacists can obtain 5 hours of ACPE credit and 5 hours of BCPP Recertification credit by successfully completing the online Clinical Application Series examination.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
Sarah L. Benner, PharmD, BCPS, BCPP
Clinical Pharmacy Coordinator and Psychiatric Clinical Pharmacist
Peninsula Regional Medical Center
Salisbury, MD
No Relevant Financial Relationships to Disclose
Mary C. Borovicka, PharmD, BCPP
Clinical Pharmacist-Dept of Psychiatry
MetroHealth Medical Center
Cleveland, OH
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Ohio Pharmacists Association - LAI and naltrexone training inj
Andria F. Church, PharmD, BCPP, BCPS
Assistant Professor
Palm Beach Atlantic University
West Palm Beach, FL
No Relevant Financial Relationships to Disclose
Beth DeJongh, PharmD, BCPP, BCPS
Recertification Editorial Board Chair
Pharmacist
Concordia University Wisconsin
Mequon, WI
No Relevant Financial Relationships to Disclose
Traci M. Dutton, PharmD, BCPP, BCPS
Clinical Pharmacy Specialist - Mental Health
VA Tennessee Valley Healthcare System
Murfreesboro, TN
No Relevant Financial Relationships to Disclose
Megan J. Ehret, PharmD, MS, BCPP
BCPP Program Director
Associate Professor
University of Maryland
Baltimore, MD
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Psych U Section Advisor, Lexi-Comp Consultant/Reviewer
Educational Grants, Research Grants or Contracts: American Society of Health System Pharmacists Research Foundation Grant, Maryland Behavioral Health Department, NIH
Non-Financial Interests: Board of Directors of CPNP
Michelle L. Geier, PharmD, BCPP
Psychiatric Clinical Pharmacist Supervisor
San Francisco Department of Public Health
San Francisco, CA
No Relevant Financial Relationships to Disclose
Rebecca Graham, PharmD, BCPP
Clinical Pharmacy Specialist - Mental Health
Corporal Michael J. Crescenz VA Medical Center in Philadelphia
Philadelphia, PA
No Relevant Financial Relationships to Disclose
Courtney A. Iuppa, PharmD, BCPP
Clinical Pharmacy Manager & Residency Program Director
Center for Behavioral Medicine
Kansas City, MO
No Relevant Financial Relationships to Disclose
Archana R. Jhawar, PharmD, BCPP
Clinical Pharmacist
Jesse Brown VAMC/ UIC College of Pharmacy
Chicago, IL
No Relevant Financial Relationships to Disclose
Monica Mathys, PharmD, BCPP, BCGP
Associate Professor
Texas Tech University School of Pharmacy
Dallas, TX
No Relevant Financial Relationships to Disclose
Jessica L. Mulhollan, PharmD, BCPP
Clinical Pharmacy Specialist, Mental Health
Louis Stokes Cleveland VA Medical Center
Canton, OH
No Relevant Financial Relationships to Disclose
Sandra Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Psychiatry
VCU Health Systems
Richmond, VA
Non-Financial Interests: Lambda Kappa Sigma Grand Council (Executive Board)
Kristen Neumeister, PharmD, BCPP
Clinical Pharmacist- Mental Health
John Peter Smith Hospital
Fort Worth, TX
No Relevant Financial Relationships to Disclose
Jake R. Peters, PharmD, BCPP, BCPS
Assistant Professor of Pharmacy Practice/Clinical Pharmacy Specialist - Psychiatry
Butler University College of Pharmacy/Indiana University Health
Indianapolis, IN
No Relevant Financial Relationships to Disclose
Sarah J. Popish, PharmD, BCPP
Academic Educator
Department of Veterans Affairs
Vallejo, CA
No Relevant Financial Relationships to Disclose
Megan M. Sarashinsky, PharmD, BCPP
Clinical Pharmacy Specialist
CJW Medical Center
Richmond, VA
No Relevant Financial Relationships to Disclose
Andrea Winterswyk, PharmD, BCPS, BCPP
Clinical Pharmacy Specialist, Mental Health
Boise Veterans Affairs Medical Center
Boise, ID
No Relevant Financial Relationships to Disclose
Kara R. Wong, PharmD, BCPP
Clinical Pharmacy Specialist, Mental Health; PGY2 Psychiatric Pharmacy Residency Program Director
Minneapolis VA Health Care System
Minneapolis, MN
No Relevant Financial Relationships to Disclose
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
In accordance with the Food and Drug Administration (FDA), it is disclosed that there is the potential for discussions concerning off-label uses of a commercial product/devices during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in this activity. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacists can obtain 5 hours of ACPE credit and 5 hours of BCPP Recertification credit by successfully completing the online Clinical Application Series examination.
Beth DeJongh, PharmD, BCPP, BCPS
Megan J. Ehret, PharmD, MS, BCPP